Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.

Jensen AD, Nikoghosyan AV, Lossner K, Haberer T, Jäkel O, Münter MW, Debus J.

Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):37-46. doi: 10.1016/j.ijrobp.2015.05.013. Epub 2015 May 19.

PMID:
26279022
2.

High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.

Jensen AD, Poulakis M, Nikoghosyan AV, Welzel T, Uhl M, Federspil PA, Freier K, Krauss J, Höss A, Haberer T, Jäkel O, Münter MW, Schulz-Ertner D, Huber PE, Debus J.

Radiother Oncol. 2015 Jul 8. pii: S0167-8140(15)00245-5. doi: 10.1016/j.radonc.2015.05.010. [Epub ahead of print]

PMID:
26164774
3.

Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.

Jensen AD, Nikoghosyan AV, Poulakis M, Höss A, Haberer T, Jäkel O, Münter MW, Schulz-Ertner D, Huber PE, Debus J.

Cancer. 2015 Sep 1;121(17):3001-9. doi: 10.1002/cncr.29443. Epub 2015 Jun 4.

PMID:
26043145
4.

Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.

Jensen AD, Poulakis M, Nikoghosyan AV, Chaudhri N, Uhl M, Münter MW, Herfarth KK, Debus J.

Radiother Oncol. 2015 Feb;114(2):182-8. doi: 10.1016/j.radonc.2015.01.002. Epub 2015 Jan 29.

5.

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.

Jensen AD, Nikoghosyan AV, Lossner K, Herfarth KK, Debus J, Münter MW.

BMC Cancer. 2012 May 2;12:163. doi: 10.1186/1471-2407-12-163.

6.

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.

Jensen AD, Krauss J, Potthoff K, Simon C, Nikoghosyan AV, Lossner K, Debus J, Münter MW.

Radiat Oncol. 2012 Apr 2;7:57. doi: 10.1186/1748-717X-7-57.

7.
8.

Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response.

Jensen AD, Nikoghosyan AV, Ecker S, Ellerbrock M, Debus J, Herfarth KK, Münter MW.

Radiat Oncol. 2011 Nov 2;6:149. doi: 10.1186/1748-717X-6-149.

9.

Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Jensen AD, Krauss J, Weichert W, Bergmann ZP, Freier K, Debus J, Münter MW.

Radiat Oncol. 2011 Sep 23;6:122. doi: 10.1186/1748-717X-6-122.

10.
11.

Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer - acute toxicity of 12C for PC.

Nikoghosyan AV, Schulz-Ertner D, Herfarth K, Didinger B, Münter MW, Jensen AD, Jäkel O, Hoess A, Haberer T, Debus J.

Acta Oncol. 2011 Aug;50(6):784-90. doi: 10.3109/0284186X.2011.584558.

PMID:
21767175
12.

Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.

Lorenzen S, von Gall C, Stange A, Haag GM, Weitz J, Haberkorn U, Lordick F, Weichert W, Abel U, Debus J, Jäger D, Münter MW.

BMC Cancer. 2011 Jun 24;11:266. doi: 10.1186/1471-2407-11-266.

13.

Re-irradiation with scanned charged particle beams in recurrent tumours of the head and neck: acute toxicity and feasibility.

Jensen AD, Nikoghosyan A, Ellerbrock M, Ecker S, Debus J, Münter MW.

Radiother Oncol. 2011 Dec;101(3):383-7. doi: 10.1016/j.radonc.2011.05.017. Epub 2011 Jun 2.

PMID:
21640421
14.

Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12).

Jensen AD, Nikoghosyan AV, Windemuth-Kieselbach C, Debus J, Münter MW.

BMC Cancer. 2011 May 22;11:190. doi: 10.1186/1471-2407-11-190.

15.
16.

Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity.

Jensen AD, Nikoghosyan AV, Ecker S, Ellerbrock M, Debus J, Münter MW.

Radiat Oncol. 2011 Apr 5;6:30. doi: 10.1186/1748-717X-6-30.

17.

Review of clinical experience with ion beam radiotherapy.

Jensen AD, Münter MW, Debus J.

Br J Radiol. 2011 Dec;84 Spec No 1:S35-47. doi: 10.1259/bjr/71511359. Epub 2011 Mar 22. Review.

18.

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy].

Jensen AD, Nikoghosyan A, Hinke A, Debus J, Münter MW.

BMC Cancer. 2011 Feb 15;11:70. doi: 10.1186/1471-2407-11-70.

19.

A clinical concept for interfractional adaptive radiation therapy in the treatment of head and neck cancer.

Jensen AD, Nill S, Huber PE, Bendl R, Debus J, Münter MW.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):590-6. doi: 10.1016/j.ijrobp.2010.10.072. Epub 2011 Feb 8.

PMID:
21310549
20.

Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique.

Rieken S, Habermehl D, Nikoghosyan A, Jensen A, Haberer T, Jäkel O, Münter MW, Welzel T, Debus J, Combs SE.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e793-801. doi: 10.1016/j.ijrobp.2010.12.018. Epub 2011 Feb 6.

PMID:
21300464
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk